Showing 1 - 10 of 21
AFP, Published on 22/12/2024
» MOSCOW - Kyiv on Saturday staged a major drone attack on the Russian city of Kazan, 1,000 kilometres (620 miles) from the frontier, the latest in a series of escalating aerial attacks in the nearly three-year conflict.
AFP, Published on 05/06/2023
» WASHINGTON - A pill has been shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor, according to clinical trial results presented on Sunday.
AFP, Published on 13/03/2023
» WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.
AFP, Published on 20/04/2022
» NEW YORK - Airlines, subways and bus services across the United States moved quickly Tuesday to remove mask requirements following a federal court ruling that struck down face-covering mandates on public transportation, a hot-button issue throughout the pandemic.
AFP, Published on 09/02/2022
» NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
AFP, Published on 28/07/2021
» LONDON - The head of the British pharmaceutical giant GSK, Emma Walmsley, will present the company's quarterly results on Wednesday as criticism mounts over ineffective management and delays in Covid-19 vaccine production.
AFP, Published on 17/03/2020
» WASHINGTON - Beds, ventilators and masks soon could all be in short supply in US hospitals rocked by the novel coronavirus, with doctors worrying they may have to start choosing which patients to treat.
AFP, Published on 16/01/2020
» TOKYO: Lurking deep inside some tumours are "factories" full of immune cells that help the body fight a rearguard action against cancer and are key to helping some patients recover, new research shows.
AFP, Published on 01/08/2019
» TOKYO - Diet is already a key part of managing diseases like diabetes and hypertension, but new research adds to a growing body of evidence that it could help cancer treatment too.
AFP, Published on 30/07/2019
» NEW YORK: Pfizer announced Monday it will merge its off-patent drug business with generic drugmaker Mylan to create a global leader in low-cost treatment, a business that faces significant political pressure in the United States.